GlaxoSmithKline CEO on why drugs cost so much

May 10, 2016
Sir Andrew Witty says that there's frankly not enough transparency when it comes to drug prices in the U.S.
Sir Andrew Witty became CEO of GlaxoSmithKline in 2008.
Courtesy of

Marketplace + Caffeine = daily dose of awesome!

Your donation today gets you two things to keep you going – your daily news fix and your new favorite mug.